metricas
covid
Buscar en
Revista de Psiquiatría y Salud Mental (English Edition)
Toda la web
Inicio Revista de Psiquiatría y Salud Mental (English Edition) Schizophrenia incidence in Spain: More questions than facts
Información de la revista
Vol. 15. Núm. 1.
Páginas 61-62 (enero - marzo 2022)
Vol. 15. Núm. 1.
Páginas 61-62 (enero - marzo 2022)
Letter to the Editor
Acceso a texto completo
Schizophrenia incidence in Spain: More questions than facts
Incidencia de esquizofrenia en España: más preguntas que certezas
Visitas
1161
Víctor Romero-Pardoa,
Autor para correspondencia
vromero@salud.madrid.org

Corresponding author.
, Franco Mascayanob,c, Ezra S. Susserb,c, Gonzalo Martínez-Alésb,d
a Servicio de Psiquiatría, Hospital Universitario de La Princesa, Madrid, Spain
b Department of Epidemiology, Columbia University Mailman School of Public Health, New York, United States
c New York State Psychiatric Institute, New York, United States
d Centro de Investigación Biomédica en Red Salud Mental (CIBERSAM)
Este artículo ha recibido
Información del artículo
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Figuras (1)
Texto completo
Dear Editor,

Schizophrenia and other non-affective psychoses are often disabling conditions that begin as early as adolescence and have an enormous impact on health and social systems. It is a public health priority to improve prevention of schizophrenic psychosis. A necessary step in this prevention would be to expand our limited knowledge of the causes of the psychosis, for which studying disease incidence is crucial: the epidemiological method typically generates causal hypotheses by comparing incidences in different populations, times, and places.1 Knowing the incidence of a disorder also allows health planning to be tailored to the needs of the population. However, identifying new cases of non-affective psychosis is a challenge: in many cases these are syndromes of insidious onset, with non-specific early manifestations that variably precede the development of the full picture, and whose symptoms may fluctuate, change, or disappear over time.

There are 2 main designs for studying the incidence of psychosis. On the one hand, first contact studies, developed from the 1970s onwards by the World Health Organisation in the framework of the Ten Country Study,2 are based on identifying people who contact health systems for the first time for reasons consistent with a psychotic disorder. On the other hand, analyses of health records, which are generally more sensitive,3 identify all people given a first diagnosis of non-affective psychosis in a space-time window (Fig. 1). These studies have revealed higher and more varied incidence rates of schizophrenia than was thought a few decades ago,4 rejecting the old belief in a constant global incidence.

Figure 1.

Types of incidence in psychosis and corresponding methodology for estimating it (drawn up by the authors).

(0.37MB).

No nationally representative study of the incidence of psychosis has been conducted to date in Spain. Some local studies have yielded heterogeneous results: a first contact study in Cantabria estimated 20 cases per 100,000 people aged 15–54 years per year,5 and another study using records from Barcelona found 51 cases for the same denominator.6 A recent European study has renewed interest in the subject by finding unusually low incidence rates in some areas of Spain (and Italy), compared to areas in more northern countries.7 Moreover, surprisingly, Jongsma et al. found no association between incidence of psychosis and population density in Spain, in contrast to studies in northern Europe8 that exposure to an urban environment increases and could double the risk of schizophrenia.

The causes of psychosis, like those of all disease, can act at different levels, both infra-individual – gene, neuron – and beyond the individual – at the level of neighbourhoods, societies – (Schwartz et al., 1999).9 For example, according to the paradigm that is currently most accepted, an urban environment would determine specific ways of interrelating, favouring processes of discrimination or interpersonal support involved in the onset of schizophrenia. The apparent discrepancies or exceptions recently identified in southern Europe raise questions that are also opportunities to broaden our understanding of the aetiology of psychosis. For example, is it plausible that, in Spain, the incidence of psychosis is not associated with the degree of urbanisation, or is this a design or measurement error? If this is a real finding, what sociological components of the 'urban environment' construct (discrimination or interpersonal support, social fragmentation, or cohesion, etc.) behave differently in Spain compared to other Western countries? In this regard, it is interesting to note that the association between the incidence of psychosis and urban environment has not been reported in countries of the global South, such as Brazil.10

There are now longitudinal electronic case registries in our country, as well as a myriad of socio-demographic, economic and cultural variables, which are measured both at the individual level and the ecological level, such as, for example, postcodes. By combining data from both sources, we will be able to propose and test hypotheses about the specific causal role played by urban planning and other ecological variables in the incidence of psychosis in Spain and other culturally proximate countries. We also believe that conducting incidence studies based on nationally representative clinical registries will enable health planning that is more appropriate to the real dimension of the problem and its impact on our communities.

Funding

This paper was possible thanks to a grant to rotate abroad, awarded to the first author by the Fundación Española de Psiquiatría y Salud Mental.

References
[1]
E. Susser, S. Schwartz, A. Morabia, E.J. Bromet.
Psychiatric epidemiology: searching for the causes of mental disorders.
Oxford University Press, (2006),
[2]
A. Jablensky, N. Sartorius, G. Ernberg, M. Anker, A. Korten, J.E. Cooper, et al.
Schizophrenia: manifestations, incidence and course in different cultures A World Health Organization Ten-Country Study.
Psychol Med (Monograph Suppl), 20 (1992), pp. 1-9
[3]
S.J. Hogerzeil, A.M. Van Hemert, F.R. Rosendaal, E. Susser, H.W. Hoek.
Direct comparison of first-contact versus longitudinal register-based case finding in the same population: early evidence that the incidence of schizophrenia may be three times higher than commonly reported.
Psychol Med, 44 (2014), pp. 3481-3490
[4]
J. McGrath, S. Saha, J. Welham, O. El Saadi, C. MacCauley, D. Chant.
A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology.
[5]
J.L. Vázquez-Barquero, M.J. Cuesta, S.H. Castanedo, I. Lastra, A. Herrán, G. Dunn.
Cantabria first-episode schizophrenia study: three-year follow-up.
Br J Psychiatry, 174 (1999), pp. 141-149
[6]
J.L. Tizón, J. Ferrando, A. Parés, J. Artigué, B. Parra, C. Pérez.
Trastornos esquizofrénicos en la atención primaria a la salud mental.
Aten Primaria, 39 (2007), pp. 119-124
[7]
H.E. Jongsma, C. Gayer-Anderson, A. Lasalvia, D. Quattrone, A. Mulè, A. Szöke, et al.
Treated incidence of psychotic disorders in the multinational EU-GEI study.
JAMA Psychiatry, 75 (2018), pp. 36-46
[8]
E. Vassos, C.B. Pedersen, R.M. Murray, D.A. Collier, C.M. Lewis.
Meta-analysis of the association of urbanicity with schizophrenia.
Schizophrenia Bull, 38 (2012), pp. 1118-1123
[9]
S. Schwartz, E. Susser, M. Susser.
A future for epidemiology?.
Ann Rev Public Health, 20 (1999), pp. 15-33
[10]
C.M. Del-Ben, R. Shuhama, C.M. Loureiro, T.C.C. Ragazzi, D.P. Zanatta, S.H.G. Tenan, et al.
Urbanicity and risk of first-episode psychosis: incidence study in Brazil.
Br J Psychiatry, 215 (2019), pp. 726-729

Please cite this article as: Romero-Pardo V, Mascayano F, Susser ES, Martínez-Alés G. Incidencia de esquizofrenia en España: más preguntas que certezas. Rev Psiquiatr Salud Ment (Barc). 2022;15:61–62.

Copyright © 2021. SEP y SEPB
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos